Proskauer Rose LLP | European Union, USA | 11 Jul 2023
On June 29, 2023, the Federal Trade Commission published a Notice of Proposed Rulemaking that would dramatically expand HSR reporting requirements…
Proskauer Rose LLP | USA | 20 Oct 2022
"We continue to see interest across the health care M&A vertical and buyers need to be ready to move quickly when attractive assets come on the…
Proskauer Rose LLP | USA | 12 Oct 2021
As the saying goes, “the only thing for certain, is nothing is certain.” With a rash of changes since Chairperson Lina Kahn took command, the FTC is…
Proskauer Rose LLP | USA | 23 Jun 2021
After a bit of hiatus on aggressively challenging vertical mergers, regulators both here in the United States and abroad have resumed initiated…
Proskauer Rose LLP | USA | 1 Mar 2021
The Sherman Act was passed in 1890. The Clayton Act in 1914. And they have hardly changed since. Last month, Senator Amy Klobuchar, the new chair of…
Proskauer Rose LLP | USA | 8 Oct 2020
Megamergers that deprive the American consumer of competition are illegal. But the urge to merge is…
Video
Proskauer Rose LLP | USA | 21 Jun 2017
Potential changes in antitrust enforcement philosophy could lead to more M&A deals, a decrease in transaction costs and shorter review…
Proskauer Rose LLP | USA | 10 May 2017
Efficiencies, economies of scale, and the general desire to improve the customer experience are the lifeblood of all mergers. And…
Proskauer Rose LLP | USA | 15 Feb 2017
In a move that may not have stood up under the new administration, the U.S. Department of Justice Antitrust Division settled a matter during the last…
Proskauer Rose LLP | USA | 24 Jan 2017
The Federal Trade Commission has announced revisions to HSR Act and Clayton Act Section 8 thresholds, which are indexed annually to account for…